FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bernard Weisblum

Research Profile

Concepts & Ideas

Genes & Molecular Sequences

Chemicals & Drugs

Living Beings

Physiology

Procedures

Microbial Sensitivity Tests

Co-author Network

Publications

TOP 3
Matthew G Erickson; Andrew T Ulijasz; Bernard Weisblum
Screening for compounds that affect the interaction between bacterial two-component signal transduction response regulator protein and cognate promoter DNA.
Brendan P Mowery; Sarah E Lee; Denis A Kissounko; Raquel F Epand; Richard M Epand; Bernard Weisblum; Shannon S Stahl; Samuel H Gellman
Mimicry of antimicrobial host-defense peptides by random copolymers.
Shaun P Falk; Andrew T Ulijasz; Bernard Weisblum
Differential assay for high-throughput screening of antibacterial compounds.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bernard Weisblum (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Matthew G Erickson; Andrew T Ulijasz; Bernard Weisblum
Screening for compounds that affect the interaction between bacterial two-component signal transduction response regulator protein and cognate promoter DNA.
Methods in molecular medicine 2008;142():215-22.
2007: Brendan P Mowery; Sarah E Lee; Denis A Kissounko; Raquel F Epand; Richard M Epand; Bernard Weisblum; Shannon S Stahl; Samuel H Gellman
Mimicry of antimicrobial host-defense peptides by random copolymers.
Journal of the American Chemical Society 2007;129(50):15474-6.
2007: Shaun P Falk; Andrew T Ulijasz; Bernard Weisblum
Differential assay for high-throughput screening of antibacterial compounds.
Journal of biomolecular screening 2007;12(8):1102-8.
2007: Margaret A Schmitt; Bernard Weisblum; Samuel H Gellman
Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides.
Journal of the American Chemical Society 2007;129(2):417-28.
2006: Jonathan Lai; Raquel F Epand; Bernard Weisblum; Richard M Epand; Samuel H Gellman
Roles of salt and conformation in the biological and physicochemical behavior of protegrin-1 and designed analogues: correlation of antimicrobial, hemolytic, and lipid bilayer-perturbing activities.
Biochemistry 2006;45(51):15718-30.
2006: Jingbo Xiao; Bernard Weisblum; Peter Wipf
Trisubstituted (E)-alkene dipeptide isosteres as beta-turn promoters in the gramicidin S cyclodecapeptide scaffold.
Organic letters 2006;8(21):4731-4.
2006: Amy J Karlsson; William C Pomerantz; Bernard Weisblum; Samuel H Gellman; Sean P Palecek
Antifungal activity from 14-helical beta-peptides.
Journal of the American Chemical Society 2006;128(39):12630-1.
2005: Emilie A Porter; Bernard Weisblum; Samuel H Gellman
Use of parallel synthesis to probe structure-activity relationships among 12-helical beta-peptides: evidence of a limit on antimicrobial activity.
Journal of the American Chemical Society 2005;127(32):11516-29.
2005: Jingbo Xiao; Bernard Weisblum; Peter Wipf
Electrostatic versus steric effects in peptidomimicry: synthesis and secondary structure analysis of gramicidin S analogues with (E)-alkene peptide isosteres.
Journal of the American Chemical Society 2005;127(16):5742-3.
2005: Matthew G Erickson; Andrew T Ulijasz; Bernard Weisblum
Bacterial 2-component signal transduction systems: a fluorescence polarization screen for response regulator-protein binding.
Journal of biomolecular screening 2005;10(3):270-4.
2004: Andrew T Ulijasz; David Andes; Jeremy D Glasner; Bernard Weisblum
Regulation of iron transport in Streptococcus pneumoniae by RitR, an orphan response regulator.
Journal of bacteriology 2004;186(23):8123-36.
2004: Jonathan Lai; John D Fisk; Bernard Weisblum; Samuel H Gellman
Hydrophobic core repacking in a coiled-coil dimer via phage display: insights into plasticity and specificity at a protein-protein interface.
Journal of the American Chemical Society 2004;126(34):10514-5.
2004: Woo-Hyeon Byeon; Bernard Weisblum
Affinity adsorbent based on combinatorial phage display peptides that bind alpha-cobratoxin.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;805(2):361-3.
2004: Margaret A Schmitt; Bernard Weisblum; Samuel H Gellman
Unexpected relationships between structure and function in alpha,beta-peptides: antimicrobial foldamers with heterogeneous backbones.
Journal of the American Chemical Society 2004;126(22):6848-9.
2004: Michael A Gelman; Bernard Weisblum; David M Lynn; Samuel H Gellman
Biocidal activity of polystyrenes that are cationic by virtue of protonation.
Organic letters 2004;6(4):557-60.
2002: Tami L Raguse; Emilie A Porter; Bernard Weisblum; Samuel H Gellman
Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency.
Journal of the American Chemical Society 2002;124(43):12774-85.
2002: Jonathan Lai; Bayard R Huck; Bernard Weisblum; Samuel H Gellman
Design of non-cysteine-containing antimicrobial beta-hairpins: structure-activity relationship studies with linear protegrin-1 analogues.
Biochemistry 2002;41(42):12835-42.
2002: Emilie A Porter; Bernard Weisblum; Samuel H Gellman
Mimicry of host-defense peptides by unnatural oligomers: antimicrobial beta-peptides.
Journal of the American Chemical Society 2002;124(25):7324-30.
2002: Paul R LePlae; John D Fisk; Emilie A Porter; Bernard Weisblum; Samuel H Gellman
Tolerance of acyclic residues in the beta-peptide 12-helix: access to diverse side-chain arrays for biological applications.
Journal of the American Chemical Society 2002;124(24):6820-1.
2000: Andrew T Ulijasz; Brian Kay; Bernard Weisblum
Peptide analogues of the VanS catalytic center inhibit VanR binding to its cognate promoter.
Biochemistry 2000;39(37):11417-24.
2000: R B Giannattasio; Bernard Weisblum
Modulation of erm methyltransferase activity by peptides derived from phage display.
Antimicrobial agents and chemotherapy 2000;44(7):1961-3.
2000: Emilie A Porter; Xiaodong Wang; Hee-Seung Lee; Bernard Weisblum; Samuel H Gellman
Non-haemolytic beta-amino-acid oligomers.
Nature 2000;404(6778):565.
1999: Bernard Weisblum
Back to Camelot: defining the specific role of tRNA in protein synthesis.
Trends in biochemical sciences 1999;24(6):247-50.
1999: Andrew T Ulijasz; Bernard Weisblum
Dissecting the VanRS signal transduction pathway with specific inhibitors.
Journal of bacteriology 1999;181(2):627-31.
1998: Bernard Weisblum
Macrolide resistance.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 1998;1(1):29-41.
1997: E Memili; Bernard Weisblum
Essential role of endogenously synthesized tylosin for induction of ermSF in Streptomyces fradiae.
Antimicrobial agents and chemotherapy 1997;41(5):1203-5.
1997: S Kamimiya; Bernard Weisblum
Induction of ermSV by 16-membered-ring macrolide antibiotics.
Antimicrobial agents and chemotherapy 1997;41(3):530-4.
1996: A T Ulijasz; A Grenader; Bernard Weisblum
A vancomycin-inducible lacZ reporter system in Bacillus subtilis: induction by antibiotics that inhibit cell wall synthesis and by lysozyme.
Journal of bacteriology 1996;178(21):6305-9.
1995: D Kovalic; R B Giannattasio; Bernard Weisblum
Methylation of minimalist 23S rRNA sequences in vitro by ErmSF (TlrA) N-methyltransferase.
Biochemistry 1995;34(48):15838-44.
1995: Bernard Weisblum
Insights into erythromycin action from studies of its activity as inducer of resistance.
Antimicrobial agents and chemotherapy 1995;39(4):797-805.
1995: Bernard Weisblum
Erythromycin resistance by ribosome modification.
Antimicrobial agents and chemotherapy 1995;39(3):577-85.
1994: D Kovalic; R B Giannattasio; H J Jin; Bernard Weisblum
23S rRNA domain V, a fragment that can be specifically methylated in vitro by the ErmSF (TlrA) methyltransferase.
Journal of bacteriology 1994;176(22):6992-8.
1994: J H Kwak; Bernard Weisblum
Regulation of plasmid pE194 replication: control of cop-repF operon transcription by Cop and of repF translation by countertranscript RNA.
Journal of bacteriology 1994;176(16):5044-51.
1991: D Kovalic; J H Kwak; Bernard Weisblum
General method for direct cloning of DNA fragments generated by the polymerase chain reaction.
Nucleic acids research 1991;19(16):4560.
1991: J H Kwak; Eung-Chil Choi; Bernard Weisblum
Transcriptional attenuation control of ermK, a macrolide-lincosamide-streptogramin B resistance determinant from Bacillus licheniformis.
Journal of bacteriology 1991;173(15):4725-35.
1990: W H Byeon; Bernard Weisblum
Replication genes of plasmid pE194-cop and repF: transcripts and encoded proteins.
Journal of bacteriology 1990;172(10):5892-900.
1989: P Sandler; Bernard Weisblum
Erythromycin-induced ribosome stall in the ermA leader: a barricade to 5'-to-3' nucleolytic cleavage of the ermA transcript.
Journal of bacteriology 1989;171(12):6680-8.
1988: P Sandler; Bernard Weisblum
Erythromycin-induced stabilization of ermA messenger RNA in Staphylococcus aureus and Bacillus subtilis.
Journal of molecular biology 1988;203(4):905-15.
1988: S Kamimiya; Bernard Weisblum
Translational attenuation control of ermSF, an inducible resistance determinant encoding rRNA N-methyltransferase from Streptomyces fradiae.
Journal of bacteriology 1988;170(4):1800-11.
1985: W H Byeon; Bernard Weisblum
Post-transcriptional regulation of chloramphenicol acetyl transferase.
Basic life sciences 1985;30():823-34.
1984: W H Byeon; Bernard Weisblum
Post-transcriptional regulation of chloramphenicol acetyl transferase.
Journal of bacteriology 1984;158(2):543-50.
1983: S Horinouchi; W H Byeon; Bernard Weisblum
A complex attenuator regulates inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis.
Journal of bacteriology 1983;154(3):1252-62.